Shafique Virani serves as Executive at RECURSION PHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Shafique Virani has executed 60 insider transactions totaling $4.2M, demonstrating a bearish approach to their equity position. Their most recent transaction on Jan 16, 2024 involved selling 18,000 shares valued at $196.7K.
Shafique Virani currently holds 136,748 shares of RECURSION PHARMACEUTICALS, INC. (RXRX), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Shafique Virani has been a net seller of RXRX stock. They have purchased $0 and sold $4.2M worth of shares.
Shafique Virani's most recent insider trade was on Jan 16, 2024, when they sold 18,000 shares at $10.93 per share.
Get notified when new Form 4 filings are submitted
| $2.22 |
| Planned |
| Dec 15, 2023 | RXRX | $40.0K | Option Exercise | 18,000 | $2.22 | Planned |
| Dec 15, 2023 | RXRX | $172.8K | Sale | 18,000 | $9.60 | Planned |
| Nov 15, 2023 | RXRX | $25.9K | Payment | 3,603 | $7.18 | Planned |
| Nov 15, 2023 | RXRX | $117.2K | Sale | 18,000 | $6.51 | Planned |
| Nov 15, 2023 | RXRX | $40.0K | Option Exercise | 18,000 | $2.22 | Planned |
| Oct 16, 2023 | RXRX | $113.4K | Sale | 18,000 | $6.30 | Planned |
| Oct 16, 2023 | RXRX | $40.0K | Option Exercise | 18,000 | $2.22 | Planned |
| Sep 15, 2023 | RXRX | $155.9K | Sale | 18,000 | $8.66 | Planned |
| Sep 15, 2023 | RXRX | $40.0K | Option Exercise | 18,000 | $2.22 | Planned |
| Aug 15, 2023 | RXRX | $40.0K | Option Exercise | 18,000 | $2.22 | Planned |
| Aug 15, 2023 | RXRX | $166.5K | Sale | 18,000 | $9.25 | Planned |
| Aug 15, 2023 | RXRX | $33.1K | Payment | 3,603 | $9.19 | Planned |
| Jul 26, 2023 | RXRX | $288.2K | Sale | 20,000 | $14.41 | Planned |
| Jul 26, 2023 | RXRX | $44.4K | Option Exercise | 20,000 | $2.22 | Planned |
| Jul 25, 2023 | RXRX | $286.0K | Sale | 20,000 | $14.30 | Planned |
| Jul 25, 2023 | RXRX | $44.4K | Option Exercise | 20,000 | $2.22 | Planned |
| Jul 18, 2023 | RXRX | $66.6K | Option Exercise | 30,000 | $2.22 | Planned |
| Jul 18, 2023 | RXRX | $412.2K | Sale | 30,000 | $13.74 | Planned |
| Jul 17, 2023 | RXRX | $66.6K | Option Exercise | 30,000 | $2.22 | Planned |
| Jul 17, 2023 | RXRX | $351.6K | Sale | 30,000 | $11.72 | Planned |
| Jun 16, 2023 | RXRX | $282.3K | Sale | 30,000 | $9.41 | Planned |
| Jun 16, 2023 | RXRX | $66.6K | Option Exercise | 30,000 | $2.22 | Planned |
| Jun 15, 2023 | RXRX | $66.6K | Option Exercise | 30,000 | $2.22 | Planned |
| Jun 15, 2023 | RXRX | $290.1K | Sale | 30,000 | $9.67 | Planned |
| Jun 2, 2023 | RXRX | $159.5K | Sale | 17,865 | $8.93 | Planned |
| Jun 1, 2023 | RXRX | $214.5K | Sale | 25,000 | $8.58 | Planned |
| May 15, 2023 | RXRX | $12.5K | Payment | 2,230 | $5.60 | Discretionary |
| Feb 16, 2023 | RXRX | $14.9K | Sale | 1,768 | $8.42 | Discretionary |